Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / RXMD - Progressive care sees 620% annual growth in COVID-19 testing to $4.3M

RXMD - Progressive care sees 620% annual growth in COVID-19 testing to $4.3M

Progressive Care Inc
Progressive Care (OTCQB:RXMD) has continued to experience strong demand for its COVID-19 testing. Q4 and annual 2021 COVID-19 testing revenue increased 132% and 620%, to $1.4M and $4.3M, respectively. “The fourth quarter was particularly strong, as we continued to market our PharmcoRx brand to corporate clients as a one-stop shop for COVID-19 testing and vaccine management solutions. We believe our positioning as a leading Florida health services organization and provider of COVID-19 testing and vaccine services will build additional value for our shareholders,” commented Alan Jay Weisberg, Chairman and CEO of RXMD. Progressive Care currently operates over 40 COVID-19 Rapid PCR Test analyzers.

For further details see:

Progressive care sees 620% annual growth in COVID-19 testing to $4.3M
Stock Information
Company Name: Progressive Care Inc
Stock Symbol: RXMD
Market: OTC
Website: progressivecareus.com
Menu
RXMD RXMD Quote RXMD Short RXMD News RXMD Articles RXMD Message Board
Get RXMD Alerts

News, Short Squeeze, Breakout and More Instantly...